How to ‘ACE’ geographical expansion in Europe
Forging the links across the value chain
Biotech companies are now at the forefront of innovation in the search for new cures and hope for patients – they are responsible for ~70% of global clinical trials (of which 42% are in partnership) and for the development of nearly half of 2018 FDA approved medicines.
Winning in the future of medtech
Medtech companies are well-positioned to drive the future of health, but most cannot do it alone. They should instead partner with consumer technology and specialized digital health companies to meet the changing market.
Patient access to innovative medicine in Europe
A bold future for life sciences regulation
Future of life sciences regulation: How industry, regulators and patients can succeed together
Ten years on
The future awakens